Abstract
The genetics of human congenital coronary vascular anomalies (hCCVA) remains largely underresearched. This is surprising, because although coronary vascular defects represent a relatively small proportion of human congenital heart disease (CHD), hCCVAs are clinically significant conditions. Indeed, hCCVA frequently associate to other congenital cardiac structural defects and may even result in sudden cardiac death in the adult. In this brief chapter, we will attempt to summarize our current knowledge on the topic, also proposing a rationale for the development of novel approaches to the genetics of hCCVA.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Laureti J, Singh K, Blankenship J. Anomalous coronary arteries : a familial clustering. Clin Cardiol. 2005;490:488–90.
Brothers JA, Stephens P, Gaynor JW, et al. Anomalous aortic origin of a coronary artery with an interarterial course: should family screening be routine? J Am Coll Cardiol. 2008;51:2062–4.
Cheitlin MD. Finding asymptomatic people with a coronary artery arising from the wrong sinus of valsalva: consequences arising from knowing the anomaly to be familial. J Am Coll Cardiol. 2008;51:2065–7.
Tomanek R. Coronary vasculature. Development, structure-function, and adaptations. New York: Springer Science; 2013.
Angelini P. Normal and anomalous coronary arteries in humans. In: Angelini P, editor. Coronary artery anomalies. Philadelphia: Lippincott, Williams and Wilkins; 1999. p. 27–150.
Maron B, Doerer J, Haas T, Tierney DM, Mueller F. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085–92.
Rigatelli G, Docali G, Rossi P, et al. Validation of a clinical-significance-based classification of coronary artery anomalies. Angiology. 2005;56:25–34.
Angelini P. Coronary artery anomalies: an entity in search of an identity. Circulation. 2007;115:1296–305.
Moodie D. Adult congenital heart disease. Curr Opin Cardiol. 1994;9:137–42.
Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17:1410–22.
Cordell HJ, Bentham J, Topf A, et al. Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nat Genet. 2013;45:822–4.
Tomita-Mitchell A, Mahnke DK, Struble CA, et al. Human gene copy number spectra analysis in congenital heart malformations. Physiol Genomics. 2012;44:518–41.
Hauser M. Congenital anomalies of the coronary arteries. Heart. 2005;91:1240–5.
Roberts R. Genetics of coronary artery disease: an update. Methodist Debakey Cardiovasc J. 2014;10:7–12.
Kathiresan S, Voight BF, Purcell S, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;41:334–41.
Schunkert H, König IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333–8.
Smith CL, Baek ST, Sung CY, Tallquist MD. Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ Res. 2011;108:e15–26.
Acharya A, Baek ST, Huang G, et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development. 2012;139:2139–49.
Iyer D, Zhao Q, Wirka R, et al. Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk. PLoS Genet. 2018;14:e1007681.
Wirka RC, Wagh D, Paik DT, et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med. 2019;25:1280–9.
Nagao M, Lyu Q, Zhao Q, et al. Coronary disease-associated gene TCF21 inhibits smooth muscle cell differentiation by blocking the myocardin-serum response factor pathway. Circ Res. 2020;126:517–29.
Gould DB, Phalan FC, Breedveld GJ, et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science. 2005;308:1167–71.
Pierpont ME, Brueckner M, Chung WK, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association. Circulation. 2018;138:e653–711.
Busè M, Cuttaia HC, Palazzo D, et al. Expanding the phenotype of reciprocal 1q21.1 deletions and duplications: a case series. Ital. J Pediatr. 2017;43:61.
Samani N, Erdmann J, Hall A, et al. Genome wide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–53.
Escot S, Blavet C, Härtle S, et al. Misregulation of SDF1-CXCR4 signaling impairs early cardiac neural crest cell migration leading to conotruncal defects. Circ Res. 2013;113:505–16.
Théveniau-Ruissy M, Dandonneau M, Mesbah K, et al. The del22q11.2 candidate gene Tbx1 controls regional outflow tract identity and coronary artery patterning. Circ Res. 2008;103:142–8.
Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003;34:383–94.
Stalmans I, Lambrechts D, De Smet F, et al. VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat Med. 2003;9:173–82.
Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Biol Dev Biol. 1995;11:73–91.
Wu B, Zhang Z, Lui W, et al. Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell. 2012;151:1083–96.
Napoli C, Armiento FPD, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. J Clin Invest. 1997;100:2680–90.
Velican C, Velican D. Coronary arteries in children up to the age of ten years II. Intimal thickening and its role in atherosclerotic involvement. Med Interne. 1976;14:17–24.
Napoli C, Witztum J, de Nigris F, et al. Intracraneal arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation. 1999;99:2003–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Garrido, A.O., Picazo, B., Guadix, J.A., Ruiz-Villalba, A., Pérez-Pomares, J.M. (2024). The Genetics of Human Congenital Coronary Vascular Anomalies. In: Rickert-Sperling, S., Kelly, R.G., Haas, N. (eds) Congenital Heart Diseases: The Broken Heart. Advances in Experimental Medicine and Biology, vol 1441. Springer, Cham. https://doi.org/10.1007/978-3-031-44087-8_48
Download citation
DOI: https://doi.org/10.1007/978-3-031-44087-8_48
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-44086-1
Online ISBN: 978-3-031-44087-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)